Use of a continuous-flow device in patients awaiting heart transplantation.

By Leslie W. Miller, F. Pagani, S. Russell, R. John, A. Boyle, Keith D. Aaronson, J. Conte, Y. Naka, D. Mancini, R. Delgado and 3 more. New England Journal of Medicine, 2007

1,653 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Surgery

View Paper: https://www.semanticscholar.org/paper/d2899fd84fcefd04c031eeba5877c2518dde82f1

Citations in the corpus

• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, methodology): “Routine repeat measurement of LV function assessment should not be performed III: No Benefit B (289, 290)”
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡ (2008, neutral): “LVAD technology is likely to undergo substantial improvement in the near future, and the recommendations will need revision accordingly.(168,169) † Current indications for LVADs and artificial hearts include bridging to transplantation and managing patients with acute, severe myocarditis.”